Crinetics Pharmaceuticals CRNX Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's operating income?
- Crinetics Pharmaceuticals (CRNX) reported operating income of -$140.38M in Q1 2026.
- How has Crinetics Pharmaceuticals's operating income changed year-over-year?
- Crinetics Pharmaceuticals's operating income decreased by 26.0% year-over-year, from -$111.41M to -$140.38M.
- What is the long-term trend for Crinetics Pharmaceuticals's operating income?
- Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's operating income has grown at a 48.0% compound annual growth rate (CAGR), from -$107.7M to -$516.77M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.